CLINICAL_TRIALS
trial_result
· 2010-03-23
Clinical Trial Update: Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study) [Phase 2]
Summary
Phase 2 ARISE trial results evaluate rituximab's immunomodulatory effects in the synovial tissue of patients with rheumatoid arthritis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Diego | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2010-03-23